All you need to know about constipation is here..
Powered by IP2Location.com
Skin signs in DM
December 16, 2008
Patients with type 2 diabetes more often develop skin infections, whereas those with type 1 more often have autoimmune-related lesions.Read more..
Influenza- update
The Cleveland Clinic Journal of Medicine has a very helpful update in its December issue. Read more..
Arthritis
Most Common Causes Of Arthritis In Small Joints Of The Hand
1. Rheumatoid arthritis (affects PIP, MCP, wrist — spares DIP and 1st MCP).
2. SLE (Jaccoud’s arthropathy: reducible, non-erosive joint deformities with a preservation of hand function).
3. Osteoarthritis (Bouchard and Herberden nodules on PIP and DIP respectively).
4. Gout (esp. chronic gouty polyarthritis).
5. Psoriatic arthritis (affects DIP and other joints of the hand).
6. Septic
7. Traumatic
Colonoscopy and Cancer Mortality.
Colonoscopy is the “gold standard” for evaluation of the colon. Now, a new study published in Annals of Internal Medicine finds colonoscopy may not be as effective as previously believed. Read this editorial.. The Original article can be read here..
ACCOMPLISH- another Hypertension trial
Still we are not sure what is the best combination treatment for hypertension. This study looked at ACE plus Ca blocker versus ACE plus Diuretic and looked at cardiovascluar end points. You can be sure which was better. after 36 months ARR was only 2.2% Read yourself..
PCOS - Newer therapies
Treatment of PCOS has moved on from clomid in the eighties to metformin. Newer drugs like Glitazones have been tried. Combination of Metformin with Exanetide is an interesting option that has been reported recently..Read more
WPW
December 12, 2008
An ECG of a 59-year-old woman with known Wolff-Parkinson-White (WPW) syndrome is shown below. The delta (Δ) waves are small, but definite. This patient, like many patients with WPW syndrome, often does not have them at all times. The PR intervals are not short (ie, <120 ms), usually one of the diagnostic features of WPW. However, the Δ wave is the key feature and the PR interval here suggests a delay in the normal A-V conduction, sometimes called “sick Kent syndrome.” The WPW QRS is a fusion beat between the accessory pathway and the normal A-V pathway.
Movement disorders Emergencies
December 2, 2008
Movement disorder emergencies in the elderly—such as rigidity, dystonia, hyperkinetic movements, and psychiatric disturbances—are challenging to manage. Many cases are iatrogenic. In theory, some cases could be avoided by anticipating them and by avoiding polypharmacy and potentially dangerous drug interactions.Read more..
Black Hairy Tongue
Black hairy tongue, also known as lingua villosa nigra, is a painless, benign disorder caused by defective desquamation and reactive hypertrophy of the filiform papillae of the tongue. The hairy appearance is due to elongation of keratinized filiform papillae, which may have different colors, varying from white to yellowish brown to black depending on extrinsic factors (eg, tobacco, coffee, tea, food) and intrinsic factors (ie, chromogenic organisms in normal flora).
Primary Biliary Cirrhosis- Review
Primary biliary cirrhosis (PBC) is a chronic and slowly progressive cholestatic liver disease of autoimmune etiology characterized by injury of the intrahepatic bile ducts that may eventually lead to liver failure. Affected individuals are usually in their fifth to seventh decades of life at time of diagnosis, and 90% are women.readmore>..
MTX in RA
November 30, 2008
"Ten recommendations for the use of MTX in daily clinical practice focussed on RA were developed, which are evidence-based and supported by a large panel of rheumatologists, enhancing their validity and practical use.
- For patients starting MTX therapy, work-up should include clinical evaluation of risk factors for MTX toxicity, including alcohol intake; patient education; levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, complete blood count (CBC), creatinine; and chest radiographic examination obtained within the previous year. Serology for HIV, hepatitis B and hepatitis C, blood fasting glucose levels, lipid profile, and pregnancy test should also be considered.
- Oral MTX should be initiated at 10 to 15 mg/week. Depending on clinical response and tolerability, the dose should be escalated by 5 mg every 2 to 4 weeks up to 20 to 30 mg/week. For patients with inadequate clinical response or intolerance, parenteral administration should be considered.
- Prescription of at least 5 mg/week of folic acid given with MTX treatment is strongly recommended.
- When MTX is started or the dose is increased, ALT levels with or without AST, creatinine, and CBC should be checked every 1 to 1.5 months until a stable dose is reached, and every 1 to 3 months thereafter. At each visit, clinical evaluation should determine adverse effects and risk factors.
- If there is a confirmed increase in ALT/AST levels at more than 3 times the upper limit of normal (ULN), MTX should be stopped. After normalization, MTX may be reinstituted at a lower dose. If the ALT/AST levels are persistently elevated up to 3 times the ULN, the MTX dose should be adjusted. If ALT/AST levels are persistently elevated more than 3 times the ULN after discontinuation of MTX, diagnostic procedures should be considered.
- MTX is appropriate for long-term use because of its acceptable safety profile.
- In DMARD-naive patients, the balance of efficacy or toxicity favors MTX monotherapy vs combination with other conventional DMARDs. When MTX monotherapy does not control the disease, MTX should be considered as the foundation for combination therapy.
- MTX is a steroid-sparing agent that is recommended in giant-cell arteritis and polymyalgia rheumatica. It may also be considered for treatment of patients with systemic lupus erythematosus or (juvenile) dermatomyositis.
- In patients with RA who are undergoing elective orthopaedic surgery, MTX can be safely continued in the perioperative period.
- For at least 3 months before planned pregnancy, MTX should not be used for both men and women. MTX should not be used during pregnancy or breast-feeding.
Hypertension , stroke and AF
November 29, 2008
Hypertension that is poorly controlled will lead on to LVH and then to LV diastolic Dysfunction. LV dysfunction is a predictor of development of AF. Read more..
Thiazides and Diabetes
Thiazides use in treating hypertension is on the increase. Dibetogenic potential of thiqazides is well known over 25 years. Read this article that discuses the recent changes in guidelines. Read More..
Blood Quiz
A 66 y/o female with a hx of myelodysplasia, refractory anemia subtype, presents with a Hemoglobin of 9.3 g/dl with a newly reduced MCV of 59 fL . Her iron studies are significant for a ferritin of 425ng/ml, with an iron level of 245 ug/dl . a bone marrow aspirate shows increased erythroid precursors , Hemoglobin H inclusions are seen on her peripheral smear after staining with brilliant cresyl blue . Pt has no family hx of anemia & has previous hemograms that have been unremarkable. her peripheral smear stained with wright giemsa is shown above.
What is her most likely diagnosis?
The SVT - UTI Connection
Stop Smoking Now
November 26, 2008
Calcinosis Cutis
November 18, 2008
Acanthosis Nigricans
November 16, 2008
NAFLD
COPD - Evidence Based Approach
NAP BEFORE WORK
Malaria self treatment
Banjo center of brain
November 15, 2008
Alas, the banjo center of the brain is not an area well-known to neuroanatomists. To pick the optimal location for the electrodes, the surgery was performed under local anesthesia while Eddie played his banjo. He was thus able to update the surgeons in real-time as to whether the tremor was better or worse, letting them get the lead placement just right.
Weird Body Quiz
Septic Shock
Posted by arif at 7:17 PM View Comments
Labels: Infectious disease, Intensive care
Move to top of post.Mounier-Kuhn syndrome
November 14, 2008
Stroke and Imaging
Early diagnosis of stroke is essential to intervene before irreversible damage happens to brain tissue. Imaging is an important tool before even thrombolytic therapy can be considered. Read more..
Inflammatory AAA
November 13, 2008
Glycemic Burden
November 12, 2008
In order to develop strategies that optimally address the glycemic burden in type 2 diabetes, it is informative to understand the relative contributions of FPG and PPG. Monnier et al did just that in a study published in 2003.
They enrolled 290 non-insulin- and non-acarbose-using patients with type 2 diabetes. Their plasma glucose concentrations were determined at fasting and during postprandial and postabsorptive periods. The areas under the curve above fasting glucose concentrations and above 6.1 mmol/L were calculated for further evaluation of the relative contributions of postprandial and fasting glucose increments to the overall glycemic burden.. The data were analyzed by quintiles of A1c.As shown in the Figure, the relative contribution of PPG decreased progressively from the lowest (69.7%) to the highest quintile of A1c
Alpha1 Antitrypsin defeciency- A Review
November 10, 2008
Contrast Induced Nephropathy
JUPITER on Target
SMART-COP for CAP
November 9, 2008
Predicting severity of Community Acquired pneumonia can be difficult even when we use severity indexes like CURB-65 and Pneumonia severity Index. SMART-COP ss eems to a better option concludes this brief report.
The UK Department of Health has published concerns that pneumonia severity scores determined at hospital admission may underestimate the severity of pneumonia in young adults. SMART-COP (systolic blood pressure, multilobar chest radiography involvement, albumin level, respiratory rate, tachycardia, confusion, oxygenation, and arterial pH) was superior to both the CURB65 (confusion, urea, respiratory rate, systolic or diastolic blood pressure, and age 65 years) score and the Pneumonia Severity Index in predicting the need for mechanical ventilation and/or inotropic support, but SMART-COP would still incorrectly stratify 15% of patients..
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
The following are 12 points to remember about this expert consensus document:
- Nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin (ASA), are the most widely used class of medications in the United States.
- As the use of any NSAID—including COX-2-;selective agents and over-the-counter doses of traditional NSAIDs, in conjunction with cardiac-dose ASA—substantially increases the risk of ulcer complications, a gastroprotective therapy should be prescribed for at-risk patients.
- The use of low-dose ASA for cardioprophylaxis is associated with a two- to fourfold increase in upper gastrointestinal event (UGIE) risk. Enteric-coated or buffered preparations do not reduce the risk of bleeding. For patients at risk of adverse events, gastroprotection should be prescribed. The risk of UGIE increases with ASA dose escalation; thus, for the chronic phase of therapy, doses greater than 81 mg should not be routinely prescribed.
- The combination of aspirin and anticoagulant therapy (including unfractionated heparin, low molecular weight heparin, and warfarin) is associated with a clinically meaningful and significantly increased risk of major extracranial bleeding events, a large proportion from the upper GI tract. This combination should be used with established vascular, arrhythmic, or valvular indication; patients should receive concomitant proton pump inhibitors (PPIs) as well. When warfarin is added to aspirin plus clopidogrel, an international normalized ratio (INR) of 2.0-2.5 is recommended.
- Substitution of clopidogrel for ASA is not a recommended strategy to reduce the risk of recurrent ulcer bleeding in high-risk patients and is inferior to the combination of ASA + PPI.
- The combination of clopidogrel and warfarin therapy is associated with an increased incidence of major bleeding when compared with monotherapy alone. Use of combination antiplatelet and anticoagulant therapy should be considered only in cases in which the benefits are likely to outweigh the risks. When warfarin is added to aspirin plus clopidogrel, an INR of 2.0-2.5 is recommended.
- PPIs are the preferred agents for the therapy and prophylaxis of NSAID- and ASA-associated GI injury.
- Testing for and eradicating H. pylori in patients with a history of ulcer disease is recommended before starting chronic antiplatelet therapy.
- Decision for discontinuation of ASA in the setting of acute ulcer bleeding must be made on an individual basis, based on cardiac risk and GI risk assessments, to discern potential thrombotic and hemorrhagic complication
- Endoscopic therapy may be performed in high-risk cardiovascular patients on dual antiplatelet therapy, and collaboration between the cardiologist and endoscopist should balance the risks of bleeding with thrombosis with regard to the timing of cessation of antiplatelet therapy.
- Overall, in appropriate patients, oral antiplatelet therapy decreases ischemic risks, but this therapy may increase bleeding complications
- Communication between cardiologists, gastroenterologists, and primary care physicians is important to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy, but who is also at risk for or develops significant GI bleeding. Debabrata Mukherjee, M.D., F.A.C.C.
Metformin And fatty Liver
November 8, 2008
In a small Norweigian Study that compared histological proven fatty liver Metformin did not show any response in reversing fatty changes, This was presented in AASLD meeting this week. It produced weight loss while patients taking drug that was regained soon after. Hepatologists have been borrowing diabetic drugs and hoping these drugs will work in fatty liver. It is time we look at other newer options line dual PPAR inhibitors.
Hypertension and CKD
November 6, 2008
Doll's Eye
Oculocephalic reflex
Excellent flash animation showing the oculocephalic reflex doll’s eye sign.
You can see the animation here>>>.
Phobias
BALANCE AND GAIT TESTS
October 28, 2008
Music for CPR
October 27, 2008
T2DM Management Update
October 25, 2008
Water hammaer Pulse
October 23, 2008
Cruveilhier Baumgarten (CB) syndrome
Multidetector computed tomography is a noninvasive method of diagnosis, which expeditiously evaluates the overall status of portosystemic collaterals in patients with portal hypertension.On CT the paraumbilical vein is seen as a tubular structure arising in the fatty falciform ligament between the left lobe of the liver, leading from the left portal vein to veins of the anterior abdominal wall.
The network of dilated veins around the umbilicus gives a "Caput medusae" appearance.
Click on CBS...See images..
Medical records like Facebook?
As some one who is slowly getting hooked to Face book this statement sounds funny. But you should read this article because it is funny but interesting..
Read more..
Headache a Review
Headache
This useful review of causes and management of headaches reminds us that:
- Headache affects 95% of people in their lifetime
- Headache affects 75% of people in any one year
- One in 10 people have migraine
- One in 30 people have headache more often than not, for 6 months or more
- At least 90% of patients seen in a neurology outpatient clinic with headache will have migraine, tension type headache, or a chronic daily headache syndrome
- Sinister causes of headache are rare, perhaps 0.1% of all headaches in primary care
Source: Practical Neurology 2008;8:335-343
GI bleed and Anti Platelet Therapy
October 11, 2008
- All NSAIDs, including COX-2 inhibitors, raise the risk of GI ulcers and bleeding when combined with ASA taken chronically for cardioprotection.
- Even on its own, chronic ASA for cardioprotection increases the risk of upper-GI events and should generally be limited to 81 mg/day.
- Patients at increased GI bleeding risk should go on a PPI; those with a history of ulcers should be evaluated and, as appropriate, treated for Helicobacter pylori infection before starting antiplatelet therapy.
- Substituting clopidogrel for ASA doesn't cut the risk of GI bleeding and isn't as effective as the combination of ASA and a PPI.
- PPIs such as lansoprazole and omeprazole are preferred over misoprostol, sucralfate, or histamine 2 (H2)-receptor antagonists for both the prevention and treatment of gastroduodenal lesions associated with ASA and other NSAIDs.
- "Communication between cardiologists, gastroenterologists, and primary-care physicians is critical to weigh the ischemic and bleeding risks in an individual patient who needs antiplatelet therapy but who is at risk for or develops significant GI bleeding."
Surgical Cure for T2DM
October 10, 2008
Read published articles..
Assessment of Diabetic Foot- Foot Protocol
The protocol consists of a history, general examination, and an assessment of dermatologic, musculoskeletal, neurologic, and vascular factors. Details of the protocol were issued by the American Diabetes Association, with the endorsement of the American Association of Clinical Endocrinologists, in a report by Dr. Andrew J.M. Boulton and his colleagues in a task force of the ADA's Foot Care Interest Group.
The history should explore previous foot ulceration or amputation, neuropathic or peripheral vascular symptoms, impaired vision, renal replacement therapy, and tobacco use.
Key components of the diabetic foot exam include dermatologic inspection for skin status, sweating, infection, ulceration, and calluses, as well as musculoskeletal inspection for deformity (claw toes, prominent metatarsal heads, Charcot's joint) or muscle wasting.
Neurologic assessment for loss of protective sensation (LOPS) should include the use of a 10-g monofilament test, with the device placed at specific points on the bottom of the foot while the patient's eyes are closed, as well as one of these additional tests:
▸ Vibration using a 128-Hz tuning fork.
▸ Pinprick sensation.
▸ Ankle reflexes.
▸ Vibration perception threshold testing.
Vascular assessment using ankle brachial pressure index testing should be performed to determine the presence of peripheral arterial disease (PAD) in two groups of patients: those who are symptomatic (claudication, rest pain, or nonhealing ulcer) and those who have absent posterior tibial or dorsalis pedis pulses (Diabetes Care 2008;31:1679–85).
Patients assessed using the protocol should be assigned to a foot risk category from 0 to 3, with 0 being no LOPS, no PAD, and no deformity, 1 being LOPS with or without deformity, 2 being PAD with or without LOPS, and 3 being a history of ulcer or amputation.
Subsequent therapy and follow-up care should be provided according to the category assigned: Primary care monitoring is appropriate for risk categories 0 and 1, and specialist care is indicated for risk categories 2 and 3.
Melamine Milk poisoning
The Chinese press reported another 380 sick children in Beijing at the same time as they are declaring the milk safe. Though this seems to be a contradiction, my feeling is that stones in children will be showing up for months after the milk supply is clean as kidney stones can lie asymptomatic for months (years?) in the renal pelvis before spontaneously moving into the ureters where they cause pain, obstruction and hematuria.
The Taiwanese press provides a shockingly sophisticated article on the problems with our current toxicity knowledge of melamine and the associated debate on limits of safety. In addition to discuss limits of tolerability it goes into the differing methods of detection including high performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry (LC-MS/MS), gas chromatography-mass spectrometry (GC-MS). The LC-MS/MS method is apparently the most sensitive assay. One confusing aspect of the article is they swithc freely between mg/kg and ppm. One mg/kg is equal to 1 ppm.
Recognition of Inflammatory Back Pain and Ankylosing Spondylitis in Primary Care
October 7, 2008
Calin's criteria have been advocated to define Inflammatory Back Pain. These require the presence of four of the following five criteria:
- age at onset <40>
- duration of back pain >3 months,
- insidious onset,
- morning stiffness
- improvement with exercise
Rudwaleit criteria proposed a new candidate set of criteria for IBP, which consisted of
- morning stiffness of >30 min duration,
- improvement in back pain with exercise but not with rest,
- nocturnal awakening (second half of the night only)
- alternating buttock pain.
OCTOBER QUIZ-2008
October 4, 2008
Below is his chest x-ray. Click on cxr..
Glucosamine for OA
October 2, 2008
Ref: Sawitzke AD et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the Glucosamine/chondroitin Arthritis Intervention Trial. Arthritis & Rheumatism 58:3183-3191, 2008
Thrombolytics in Acute Stroke? Time is brain
September 28, 2008
According to this article in the September 25th edition of the New England Journal of Medicine, alteplase improves the outcomes in stroke patients up to 4.5 hours after symptom onset. Previously, the “window” of effectiveness was only three hours. The clinical trial criteria are here.
The percentage of patients having a favorable outcome at 90 days in this study wasn’t huge, but was statistically significant - 52% of patients receiving alteplase had good outcomes compared with 45% of patients who received placebo. At the same time 27% of patients had some type of bleeding after receiving thrombolytics compared with only 17% of patients who had bleeding after receiving placebo. The rate of symptomatic bleeding in the brain was 2.4% for thrombolytics versus 0.2% for placebo.
So while you may have an overall improvement in your outcome at 90 days if you get the medication, more than 1 in 4 patients who receive the medication will have bleeding and 1 in 40 patients will have symptomatic bleeding.
Is it worth the risk?
In the editorial article accompanying the study, one of the study authors states that “one cannot help wondering why thrombolytic therapy has traveled such a long, difficult path to wider clinical use.”
I can help wondering.
Thrombolytics are one of the few things that physicians can give that will have an immediate and significant harm on patients. Sure, patients may occasionally have bad outcomes from allergic events or they may have undesirable side effects from some medications. But 2.4% of patients will have symptomatic bleeding in their brains when they get thrombolytics. Some of those patients will die.
I like to pose this scenario to my trainees: a patient presents to you 30 minutes after the onset of a left hemispheric stroke; how long do you have to initiate thrombolytic therapy?
The correct answer is 1 minute, not 2.5 hours, and ECASS III does not now justify an answer of 4 hours. From the moment the patient arrives at the door, every minute counts, and the only justifiable delays would be for performing brain imaging studies to exclude hemorrhage and for obtaining the results of a few simple laboratory tests. In fact, the very real peril of the ECASS III data is that some may take an even more leisurely approach to treating acute stroke. Nothing could be more wrong, for as we look back on the past decade of thrombolytic therapy for stroke, it is very clear that our focus must remain on the door-to-needle time. Every minute matters during a stroke.
So the choice is …
1. Let patient continue with the stroke symptoms they have already presented with and follow the doctrine of “primum non nocere.” After all, even this study shows that if doctors do nothing, 45% of the patients will get better on their own.
-or-
2. Give a medication that may improve clinical outcome in 7% more of the patients … at the risk of getting a bad outcome from the medication.
What would you choose?
Want a simple way to immediately expand the use of thrombolytic therapy?
If an On Call physician gets a CT report from a radiologist that says “no bleed,” the patient meets the criteria for thrombolytic therapy and doesn’t have any exclusion criteria, then the Physician cannot be held liable for any bad outcomes for giving thrombolytics.
There will still be some that philosophically disagree with giving patients a medication that could kill them. Nevertheless, there would be an instant spike in thrombolytic use. I guarantee it.
New Diabetic guideline for Canada
September 26, 2008
Hypertension Mega Trials
September 25, 2008
HIT again!
September 23, 2008
DRUMSTICKS
Metabolic Syndromes and CV mortality
Posted by arif at 12:13 AM View Comments
Labels: Cardiovascular Disease, Metabolic syndrome
Move to top of post.September 22, 2008
Statins Can do Everything?
Treatment with a statin resulted in about a 2-2.5 point drop in SBP and DBP. The treatment was stopped at 6 months, and the blood pressures returned to baseline by month 8 - further suggesting that this was a true effect.
Beatrice A. Golomb; Joel E. Dimsdale; Halbert L. White; Janis B. Ritchie; Michael H. Criqui
Reduction in Blood Pressure With Statins: Results From the UCSD Statin Study, a Randomized Trial
Arch Intern Med. 2008;168(7):721-727.
Another Cause for Intermittent Jaundice
Elderly lady comes in with recurrent RUQ pain and jaundice. US shows gallstones and a dilated common bile duct. No stones seen in the CBD on MRCP. The GI consultant attempts an ERCP but the common duct cannot be cannulated secondary to a peri-ampullary diverticulum, noted to be full of food matter. I obtain the Upper GI barium study shown above.
Intermittent jaundice has been <>described in association with peri-ampullary duodenal diverticula, although it's quite rare. Options include formally excising the diverticulum versus simply bypassing the distal segment of the CBD with a biliary-enteric anastomosis.
Syndicated from Buckeye surgeon
New Hep B Recommendations
- <>The CDC just issued new testing recommendations for chronic Hep B virus infection.
Serologic testing for hepatitis B surface antigen (HBsAg) is the primary way to identify persons with chronic hepatitis B virus (HBV) infection. Testing has been recommended previously for pregnant women, infants born to HBsAg-positive mothers, household contacts and sex partners of HBV-infected persons, persons born in countries with HBsAg prevalence of >8%, persons who are the source of blood or body fluid exposures that might warrant postexposure prophylaxis (e.g., needlestick injury to a health-care worker or sexual assault), and persons infected with human immunodeficiency virus.- This report updates and expands previous CDC guidelines for HBsAg testing and includes new recommendations for public health evaluation and management for chronically infected persons and their contacts. Routine testing for HBsAg now is recommended for additional populations with HBsAg prevalence of >2%: persons born in geographic regions with HBsAg prevalence of >2%, men who have sex with men, and injection-drug users.
- Implementation of these recommendations will require expertise and resources to integrate HBsAg screening in prevention and care settings serving populations recommended for HBsAg testing. This report is intended to serve as a resource for public health officials, organizations, and health-care professionals involved in the development, delivery, and evaluation of prevention and clinical services.
Endo Barrier for T2DM
Home Blood pressure Monitoring
September 19, 2008